28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Decoding the research landscape of drug resistance and therapeutic approaches in head and neck cancer: a bibliometric analysis from 2000 to 2023

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction:

          Head and neck cancer is one of the most common tumors worldwide. However, drug resistance in its treatment has become a major factor limiting the efficacy. This study aims to comprehensively understand the current status of research in this field.

          Methods:

          The study analyzes papers related to therapeutic resistance in head and neck cancer published between 2000 and 2023 in the Web of Science Core Collection To achieve the research objectives, we searched the WoSCC for research and review papers on therapeutic resistance in head and neck cancer from 2000 to 2023, screened the English literature, and analyzed the research hotspots, academic collaborations, and trends in detail using tools such as Citespace, SCImago Graphica, and VOS viewer.

          Results:

          This study summarizes 787 head and neck cancer treatment resistance publications from WoSCC. The analysis showed that China and the United States are the major contributors in this field, and Grandis Jennifer R and Yang Jai-Sing are the key scholars. Keyword analysis showed that “cisplatin resistance” is a continuing focus of attention, while “Metastasis” and “Ferroptosis” may be emerging research hotspots. Literature clustering analysis pointed out that “Ferroptosis”, “Immunotherapy” and “ERK signaling” were the recent hotspots that received extensive attention and citations. Finally, we discuss the current status and challenges in drug-resistant therapies for head and neck cancer.

          Conclusion:

          This study is the first comprehensive bibliometric analysis of drug resistance in head and neck cancer. Reveals current trends and helps researchers grasp cutting-edge hotspots in the field.

          Related collections

          Most cited references85

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer statistics, 2019

          Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the National Center for Health Statistics. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2006-2015) was stable in women and declined by approximately 2% per year in men, whereas the cancer death rate (2007-2016) declined annually by 1.4% and 1.8%, respectively. The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with the most notable gaps for the most preventable cancers. For example, compared with the most affluent counties, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016. Some states are home to both the wealthiest and the poorest counties, suggesting the opportunity for more equitable dissemination of effective cancer prevention, early detection, and treatment strategies. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            bibliometrix : An R-tool for comprehensive science mapping analysis

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Silhouettes: A graphical aid to the interpretation and validation of cluster analysis

                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2369522/overviewRole: Role: Role: Role: Role: Role: Role: Role: Role: Role: Role:
                Role: Role: Role:
                Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2425044/overviewRole: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2408132/overviewRole: Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2432176/overviewRole: Role: Role:
                Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2262774/overviewRole: Role: Role:
                Role: Role: Role: Role:
                Role: Role: Role: Role: Role:
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                05 April 2024
                2024
                : 15
                : 1375110
                Affiliations
                [1] 1 Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer , First Hospital of Shanxi Medical University , Taiyuan, China
                [2] 2 Shanxi Province Clinical Medical Research Center for Precision Medicine of Head and Neck Cancer , First Hospital of Shanxi Medical University , Taiyuan, China
                [3] 3 Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer , The First Clinical Medical College of Shanxi Medical University , Taiyuan, China
                [4] 4 Department of Cardiology , Shanxi Cardiovascular Hospital , Taiyuan, China
                [5] 5 Department of Otolaryngology Head and Neck Surgery , First Hospital of Shanxi Medical University , Taiyuan, China
                [6] 6 Department of Cell Biology and Genetics , the Basic Medical School of Shanxi Medical University , Taiyuan, Shanxi, China
                Author notes

                Edited by: Ana Sofia Fernandes, Universidade Lusófona Research Center for Biosciences and Health Technologies, Portugal

                Reviewed by: Olesya A. Kharenko, Syantra Inc., Canada

                Harim Tavares Dos Santos, University of Missouri, United States

                *Correspondence: Chunming Zhang, zcmsxmu@ 123456sxent.org ; Qi Han, hanqi798@ 123456gmail.com
                Article
                1375110
                10.3389/fphar.2024.1375110
                11026562
                38645557
                a2f5dd9b-2858-4341-acc1-091595fdcf38
                Copyright © 2024 Han, Shi, Liu, Fu, Li, Guo, Guan, Xue, Liu, Zhao and Zhang.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 23 January 2024
                : 25 March 2024
                Funding
                Funded by: Natural Science Foundation of Shanxi Province , doi 10.13039/501100004480;
                Award ID: 202203021211015 202203021212036 202203021212032 202203021212029 202103021223430
                Funded by: Shanxi Provincial Education Department , doi 10.13039/501100013794;
                Award ID: 2022L133 2022L135
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Basic Research Program of Shanxi Province (Free Exploration) (No. 202203021212036, 202203021211015, 202203021212032, 202203021212034), Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi (No. 2022L133, 2022L135).
                Categories
                Pharmacology
                Original Research
                Custom metadata
                Pharmacology of Anti-Cancer Drugs

                Pharmacology & Pharmaceutical medicine
                head and neck cancer,drug resistance,bibliometric analysis,research frontiers,data visualization

                Comments

                Comment on this article